On November 11, MEDICA 2024, one of the world's largest medical trade fairs, opened in Düsseldorf, Germany. The event gathers top international medical technologies and innovations. Biolight, a leading Chinese medical device company, showcases cutting-edge products and solutions, highlighting the strength and potential of "Chinese creation."

NewBase, New Pages

At the MEDICA 2024, Biolight (BLT) officially announced the launch of its new production base, which features state-of-the-art facilities. With this new base, BLT will enhance its research and manufacturing capabilities in the medical technology sector and is confident in bringing more innovative products and solutions to the global healthcare industry.

SmartProducts, Stunning Entrance

Biolight's products and solutions showcased at the trade fairs became the focal point. Remote View, with its powerful real-time monitoring and multi-patient management capabilities, garnered widespread attention. Healthcare professionals can easily view information from the monitors and manage multiple patients in real-time through an app or other mobile devices, receiving alerts as needed. This significantly enhances care efficiency and patient safety.

Another highly acclaimed solution is Biofluid, which offers comprehensive fluid management. This solution integrates multiple devices, including the BIOFUSION infusion and syringe pump, high-end parameter monitor, and the UM100 urine monitor, to provide all-around fluid management. Whether in critical operating rooms (ORs), sub-intensive ICUs, or other departments, and whether for neonates or elderly patients, Biofluid delivers precise and efficient fluid management solutions, providing strong support for clinical diagnosis and treatment.

In the field of blood purification, Biolight showcased its strong technical capabilities and innovative spirit. The D800Plus, China's first three-pump hemodiafiltration device, has attracted significant attention from both domestic and international clients due to its superior performance and comprehensive solutions. Its features—such as a high-sensitivity touchscreen, real-time information retrieval via IC cards, and six professional curve configurations—not only cater to diverse clinical needs but also highlight Biolight's commitment to quality and innovation.

In addition, the trade fair also featured Biolight's peritoneal dialysis equipment and its core consumables, showcasing the company's comprehensive layout and deep expertise in the field of blood purification.

During the MEDICA 2024, Biolight's Sales Director, Joseph Yan, stated, " This event serves as a vital platform for Biolight to present 'Chinese Innovation' globally. We introduced new cutting-edge product solutions that received widespread acclaim from clients worldwide. This experience deepened our understanding of the powerful impact technological innovation has on the medical industry. Biolight will continue to pursue an innovation-driven development strategy, consistently advancing our products. With an open mindset and pragmatic actions, we aim to collaborate with global partners in shaping the future of medical technology." 

The successful hosting of this year's MEDICA not only offered fresh perspectives for the global medical industry but also provided a stage for Chinese companies like Biolight to demonstrate their strength and innovation. Moving forward, Biolight will uphold the corporate spirit of "Development, Win-Win, Innovation, and Cohesion," contributing valuable insights and strength to advance the global medical sector.